Alder Biopharma
(ALDR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALDR | AZN | AMGN | GILD | BMY |
| Company | Alder Biopharma | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 18.95 | 200.08 | 365.14 | 148.90 | 60.60 |
| High | 19.12 | 201.90 | 367.74 | 156.52 | 60.89 |
| Low | 18.83 | 199.19 | 361.00 | 147.38 | 59.66 |
| Latest | 18.88 | 202.29 | 367.88 | 156.02 | 60.92 |
| Change | -0.04 | +8.89 | +3.23 | +8.79 | +0.06 |
| % Change | -0.21% | +4.60% | +0.89% | +5.97% | +0.10% |
| Volume | 29,121,700 | 1,239,791 | 707,242 | 4,400,828 | 2,534,409 |
| 20-Day Average Volume | 5,270,225 | 4,554,415 | 3,089,398 | 8,271,631 | 13,208,817 |
| Previous Close | 18.92 | 193.40 | 364.65 | 147.23 | 60.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.86 | 187.94 | 349.57 | 138.94 | 56.73 |
| 20-Day Raw Stochastic | 48.94% | 97.16% | 68.89% | 96.22% | 84.01% |
| 20-Day Relative Strength | 79.65 | 62.72 | 60.20 | 72.67 | 67.66 |
| Weighted Alpha | -4.50 | +44.29 | +31.79 | +59.78 | +24.22 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 24% Buy | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.21% since 10/14/19 | +7.03% since 02/04/26 | -0.22% since 02/04/26 | +6.01% since 02/04/26 | +5.33% since 02/04/26 |
| Low | 18.83 on 10/21/19 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 145.87 on 02/05/26 | 58.00 on 02/05/26 |
| High | 19.12 on 10/21/19 | 201.28 on 02/11/26 | 385.12 on 02/06/26 | 156.36 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +1.29% since 09/20/19 | +5.98% since 01/09/26 | +12.05% since 01/09/26 | +28.01% since 01/09/26 | +8.65% since 01/09/26 |
| Low | 18.60 on 09/23/19 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 19.12 on 10/21/19 | 201.28 on 02/11/26 | 385.12 on 02/06/26 | 156.36 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +92.26% since 07/19/19 | +12.59% since 11/11/25 | +7.96% since 11/11/25 | +26.48% since 11/11/25 | +24.57% since 11/11/25 |
| Low | 8.39 on 09/09/19 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 19.12 on 10/21/19 | 201.28 on 02/11/26 | 385.12 on 02/06/26 | 156.36 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +48.90% since 04/18/19 | +35.43% since 08/11/25 | +28.17% since 08/11/25 | +28.68% since 08/11/25 | +32.14% since 08/11/25 |
| Low | 8.39 on 09/09/19 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 19.12 on 10/21/19 | 201.28 on 02/11/26 | 385.12 on 02/06/26 | 156.36 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,582,842 | 299,945,568 | 196,357,104 | 182,665,312 | 123,895,928 |
| Shares Outstanding, K | 83,837 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -296,430,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 2.64 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 11/04/19 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 17.20 | 18.52 | 9.88 |